A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever

Andrea Marzi, Logan Banadyga, Elaine Haddock, Tina Thomas, Kui Shen, Eva J. Horne, Dana P. Scott, Heinz Feldmann, Hideki Ebihara

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Marburg virus (MARV), a close relative of Ebola virus, is the causative agent of a severe human disease known as Marburg hemorrhagic fever (MHF). No licensed vaccine or therapeutic exists to treat MHF, and MARV is therefore classified as a Tier 1 select agent and a category A bioterrorism agent. In order to develop countermeasures against this severe disease, animal models that accurately recapitulate human disease are required. Here we describe the development of a novel, uniformly lethal Syrian golden hamster model of MHF using a hamster-adapted MARV variant Angola. Remarkably, this model displayed almost all of the clinical features of MHF seen in humans and non-human primates, including coagulation abnormalities, hemorrhagic manifestations, petechial rash, and a severely dysregulated immune response. This MHF hamster model represents a powerful tool for further dissecting MARV pathogenesis and accelerating the development of effective medical countermeasures against human MHF.

Original languageEnglish (US)
Article number39214
JournalScientific Reports
Volume6
DOIs
StatePublished - Dec 15 2016

Fingerprint

Marburg Virus Disease
Marburgvirus
Virus Diseases
Cricetinae
Angola
Biological Warfare Agents
Ebolavirus
Animal Disease Models
Mesocricetus
Exanthema
Primates
Vaccines

ASJC Scopus subject areas

  • General

Cite this

A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever. / Marzi, Andrea; Banadyga, Logan; Haddock, Elaine; Thomas, Tina; Shen, Kui; Horne, Eva J.; Scott, Dana P.; Feldmann, Heinz; Ebihara, Hideki.

In: Scientific Reports, Vol. 6, 39214, 15.12.2016.

Research output: Contribution to journalArticle

Marzi, A, Banadyga, L, Haddock, E, Thomas, T, Shen, K, Horne, EJ, Scott, DP, Feldmann, H & Ebihara, H 2016, 'A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever', Scientific Reports, vol. 6, 39214. https://doi.org/10.1038/srep39214
Marzi, Andrea ; Banadyga, Logan ; Haddock, Elaine ; Thomas, Tina ; Shen, Kui ; Horne, Eva J. ; Scott, Dana P. ; Feldmann, Heinz ; Ebihara, Hideki. / A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever. In: Scientific Reports. 2016 ; Vol. 6.
@article{d445f644035a428c8a4789724a8055e1,
title = "A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever",
abstract = "Marburg virus (MARV), a close relative of Ebola virus, is the causative agent of a severe human disease known as Marburg hemorrhagic fever (MHF). No licensed vaccine or therapeutic exists to treat MHF, and MARV is therefore classified as a Tier 1 select agent and a category A bioterrorism agent. In order to develop countermeasures against this severe disease, animal models that accurately recapitulate human disease are required. Here we describe the development of a novel, uniformly lethal Syrian golden hamster model of MHF using a hamster-adapted MARV variant Angola. Remarkably, this model displayed almost all of the clinical features of MHF seen in humans and non-human primates, including coagulation abnormalities, hemorrhagic manifestations, petechial rash, and a severely dysregulated immune response. This MHF hamster model represents a powerful tool for further dissecting MARV pathogenesis and accelerating the development of effective medical countermeasures against human MHF.",
author = "Andrea Marzi and Logan Banadyga and Elaine Haddock and Tina Thomas and Kui Shen and Horne, {Eva J.} and Scott, {Dana P.} and Heinz Feldmann and Hideki Ebihara",
year = "2016",
month = "12",
day = "15",
doi = "10.1038/srep39214",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever

AU - Marzi, Andrea

AU - Banadyga, Logan

AU - Haddock, Elaine

AU - Thomas, Tina

AU - Shen, Kui

AU - Horne, Eva J.

AU - Scott, Dana P.

AU - Feldmann, Heinz

AU - Ebihara, Hideki

PY - 2016/12/15

Y1 - 2016/12/15

N2 - Marburg virus (MARV), a close relative of Ebola virus, is the causative agent of a severe human disease known as Marburg hemorrhagic fever (MHF). No licensed vaccine or therapeutic exists to treat MHF, and MARV is therefore classified as a Tier 1 select agent and a category A bioterrorism agent. In order to develop countermeasures against this severe disease, animal models that accurately recapitulate human disease are required. Here we describe the development of a novel, uniformly lethal Syrian golden hamster model of MHF using a hamster-adapted MARV variant Angola. Remarkably, this model displayed almost all of the clinical features of MHF seen in humans and non-human primates, including coagulation abnormalities, hemorrhagic manifestations, petechial rash, and a severely dysregulated immune response. This MHF hamster model represents a powerful tool for further dissecting MARV pathogenesis and accelerating the development of effective medical countermeasures against human MHF.

AB - Marburg virus (MARV), a close relative of Ebola virus, is the causative agent of a severe human disease known as Marburg hemorrhagic fever (MHF). No licensed vaccine or therapeutic exists to treat MHF, and MARV is therefore classified as a Tier 1 select agent and a category A bioterrorism agent. In order to develop countermeasures against this severe disease, animal models that accurately recapitulate human disease are required. Here we describe the development of a novel, uniformly lethal Syrian golden hamster model of MHF using a hamster-adapted MARV variant Angola. Remarkably, this model displayed almost all of the clinical features of MHF seen in humans and non-human primates, including coagulation abnormalities, hemorrhagic manifestations, petechial rash, and a severely dysregulated immune response. This MHF hamster model represents a powerful tool for further dissecting MARV pathogenesis and accelerating the development of effective medical countermeasures against human MHF.

UR - http://www.scopus.com/inward/record.url?scp=85006269843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006269843&partnerID=8YFLogxK

U2 - 10.1038/srep39214

DO - 10.1038/srep39214

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 39214

ER -